Madrid, Spain

Maria Garranzo García-Ibarrola

This inventor holds 1 USPTO granted patent. Top assignee: Pharma Mar, S.a.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Garranzo García-Ibarrola. Retrieved from https://idiyas.com/inventor/maria-garranzo-garcía-ibarrola

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Maria Garranzo García-Ibarrola: Innovator in Antitumoral Compounds

Introduction

Maria Garranzo García-Ibarrola is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of cancer treatment through her innovative research and development of antitumoral compounds. Her work is vital in the ongoing battle against cancer, showcasing her dedication to improving patient outcomes.

Latest Patents

Maria holds a patent for antitumoral compounds, specifically a compound of general formula (I) wherein various groups take on different meanings for use in the treatment of cancer. This patent represents her commitment to advancing medical science and providing new therapeutic options for patients.

Career Highlights

Maria is associated with Pharma Mar, S.A., a company known for its focus on developing innovative medicines for cancer treatment. Her role at Pharma Mar has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Maria has worked alongside notable colleagues, including Alberto Rodríguez Vicente and Carmen Murcia Pérez. These collaborations have enriched her research and expanded the impact of her work in the scientific community.

Conclusion

Maria Garranzo García-Ibarrola is a trailblazer in the development of antitumoral compounds, demonstrating her commitment to cancer research and innovation. Her contributions are essential in the fight against cancer, and her work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…